Arteris director sells 70,000 shares via 10b5-1 plan
Arteris, Inc. director Saiyed Atiq Raza reported open‑market sales of Arteris common stock made through a family trust under a pre‑arranged Rule 10b5‑1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Arteris, Inc. director Saiyed Atiq Raza reported open‑market sales of Arteris common stock made through a family trust under a pre‑arranged Rule 10b5‑1 trading plan. On June 1, 2026, the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust sold 70,000 shares in two transactions at weighted average prices of about $35.99 and $36.45 per share.
These transactions were executed in multiple trades within stated price ranges, and the filing notes that detailed trade breakdowns are available on request. After the reported activity, Raza also shows a separate direct holding of 20,839 Arteris shares.
Insider Trade Summary 10b5-1
Net Seller: 70,000 shares
Net Sell
3 txns
Insider
RAZA SAIYED ATIQ
Role
Director
Sold
70,000 shs ($2.52M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 66,400 | $35.9922 | $2.39M |
| Sale | Common Stock | 3,600 | $36.4503 | $131K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 140,000 shares (Indirect, By Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012);
Common Stock — 20,839 shares (Direct)
Footnotes (4)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.34 to $36.33 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
- F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.34 to $36.56 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Total shares sold: 70,000 shares
First block sold: 3,600 shares at $36.4503
Second block sold: 66,400 shares at $35.9922
+4 more
7 metrics
Total shares sold
70,000 shares
Open-market sales by revocable trust on June 1, 2026
First block sold
3,600 shares at $36.4503
Weighted average sale price, multiple trades
Second block sold
66,400 shares at $35.9922
Weighted average sale price, multiple trades
Direct holdings after transaction
20,839 shares
Common stock held directly by Raza following reported transactions
Trading plan adoption date
November 7, 2025
Date Rule 10b5-1 plan was adopted
Lower sale price range
$35.34–$36.33
Range for one weighted average sale block
Higher sale price range
$36.34–$36.56
Range for second weighted average sale block
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, Revocable Trust, open-market sale
4 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
Revocable Trust financial
"The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust..."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
open-market sale market
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Arteris (AIP) disclose in this Form 4?
Arteris disclosed that director Saiyed Atiq Raza, through a family revocable trust, reported open‑market sales of 70,000 shares of Arteris common stock on June 1, 2026 under a pre‑arranged Rule 10b5‑1 trading plan.
Were the Arteris (AIP) insider sales made under a Rule 10b5-1 plan?
Yes. A footnote states the transactions were made pursuant to a Rule 10b5‑1 trading plan adopted on November 7, 2025. Such plans are established in advance, which generally indicates the sales were pre‑scheduled rather than timed reactively to short‑term news.
What Arteris (AIP) holdings does director Saiyed Atiq Raza report after these transactions?
After the reported transactions, the Form 4 shows 20,839 shares of Arteris common stock held directly by Saiyed Atiq Raza. The filing also discloses continuing indirect ownership through the revocable trust, with share counts detailed in the transaction table.
How are the Arteris (AIP) sale prices described in the Form 4 filing?
Each sales line reports a weighted average sale price. Footnotes explain that shares were sold in multiple transactions within price ranges of $35.34–$36.33 and $36.34–$36.56, and that full trade‑by‑trade details are available upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates